Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-31 Sale |
2023-01-31 9:50 pm |
Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer |
2,593 | $0.24 | $622 | 59,140 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-01 9:18 pm |
Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer |
2,517 | $6.573 | $16,544 | 205,483 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-29 Exercise |
2023-01-31 9:50 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer |
16,063 | $0 | 59,140 (Direct) |
View |
| 2022-01-29 Exercise |
2022-02-01 9:18 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer |
7,438 | $0 | 205,483 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 9:18 pm |
N/A 2032-01-30 |
Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer |
178,250 | $0 | 205,483 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 8:27 pm |
N/A 2031-01-28 |
Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer |
161,000 | $0 | 161,000 (Direct) |
View |